APA (7th ed.) Citation

Hart, R. G., Sharma, M., Mundl, H., Kasner, S. E., Bangdiwala, S. I., Berkowitz, S. D., . . . Connolly, S. J. (2018). Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source. The New England journal of medicine, 378(23), 2191-2201. https://doi.org/10.1056/NEJMoa1802686

Chicago Style (17th ed.) Citation

Hart, Robert G., et al. "Rivaroxaban for Stroke Prevention After Embolic Stroke of Undetermined Source." The New England Journal of Medicine 378, no. 23 (2018): 2191-2201. https://doi.org/10.1056/NEJMoa1802686.

MLA (9th ed.) Citation

Hart, Robert G., et al. "Rivaroxaban for Stroke Prevention After Embolic Stroke of Undetermined Source." The New England Journal of Medicine, vol. 378, no. 23, 2018, pp. 2191-2201, https://doi.org/10.1056/NEJMoa1802686.